InsiderClue
Insiders · Profile

Savill Corrine

Chief Business Officer at Cullinan Therapeutics. Filing since 11 Jul 2022. CIK 0001837524

Company
Date
Role
Action
Shares
Amount
Of holding
CGEM Cullinan Therapeutics, Inc.
1 Feb 2024
Chief Business Officer
Sold on a plan
40,000
$647.20K
19.4%
CGEM Cullinan Therapeutics, Inc.
29 Jan 2024
Chief Business Officer
Sold on a plan
40,000
$563.60K
19.4%
CGEM Cullinan Therapeutics, Inc.
23 Jan 2024
Chief Business Officer
Sold on a plan
21,316
$265.60K
11.4%
CGEM Cullinan Therapeutics, Inc.
22 Jan 2024
Chief Business Officer
Sold on a plan
18,684
$226.91K
10.1%
CGEM Cullinan Therapeutics, Inc.
19 Jul 2022
Acting Chief Business Officer
Sold, plan not stated
14,958
$227.66K
9.1%
CGEM Cullinan Therapeutics, Inc.
18 Jul 2022
Acting Chief Business Officer
Sold, plan not stated
5,042
$75.93K
3.0%
CGEM Cullinan Therapeutics, Inc.
11 Jul 2022
Acting Chief Business Officer
Sold, plan not stated
40,000
$533.30K
19.1%
7 decisions on file.